Publicacións en colaboración con investigadores/as de Addenbrooke's Hospital (8)

2020

  1. Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 106, Núm. 4, pp. 733-742

2016

  1. IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 95, Núm. 5, pp. 1367-1377

2014

  1. Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): An open-label, randomised, phase 3 trial

    The Lancet Oncology, Vol. 15, Núm. 8, pp. 829-840

2008

  1. AMPK: a metabolic gauge regulating whole-body energy homeostasis

    Trends in Molecular Medicine, Vol. 14, Núm. 12, pp. 539-549

  2. Hypothalamic AMP-activated protein kinase: a master cellular sensor regulating feeding behaviour

    OBESITY AND METABOLISM-MILAN, Vol. 4, Núm. 4, pp. 199-201

  3. Hypothalamic Fatty Acid Metabolism Mediates the Orexigenic Action of Ghrelin

    Cell Metabolism, Vol. 7, Núm. 5, pp. 389-399

  4. The AMPK-Malonyl-CoA-CPT1 Axis in the Control of Hypothalamic Neuronal Function-Reply

    Cell Metabolism

2005

  1. Proopiomelanocortin-deficient mice are hypersensitive to the adverse metabolic effects of glucocorticoids

    Diabetes, Vol. 54, Núm. 8, pp. 2269-2276